The transmembrane protein TMEM219 (25 kDa) was also identified as an IGFBP‐3 receptor (termed IGFBP‐3R) in 2010, using the yeast two‐hybrid screening and a human breast cancer cell cDNA library.49 The gene discussed is TMEM219; the disease is breast carcinoma.